Skip to main content
. 2015 Nov 25;22(5-6):325–331. doi: 10.3727/096504015X14410238486522

Table 3.

Incidence of Hematological Adverse Events (n = 41, Total = 308)

Grade 1 2 3 4
Investigations
 Leukocytopenia 16 (39.0%) 2 (4.9%)
 Neutropenia 11 (26.8%) 4 (9.8%) 4 (9.8%)
 Anemia 22 (53.7%) 2 (4.9%)
 Thrombocytopenia 20 (48.8%) 1 (2.4%) 1 (2.4%)
 AST 28 (68.3%)
 ALT 20 (48.8%)
 γ-GTP 13 (31.7%) 1 (2.4%)
 Blood bilirubin increased 5 (12.2%)
 LDH 28 (68.3%)
 ALP 20 (48.8%)
 BUN 2 (4.9%)
 Cr 2 (4.9%)
Metabolism and nutrition disorders
 Hypokalemia 7 (17.1%)
 Hypoproteinemia 4 (9.8%)